Literature DB >> 2868633

Antibody response to experimental Trypanosoma rangeli infection and its implications for immunodiagnosis of South American trypanosomiasis.

F Guhl, L Hudson, C J Marinkelle, S J Morgan, C Jaramillo.   

Abstract

Differential immunodiagnosis of T. rangeli and T. cruzi infections in man poses a particular problem, not only because these parasites share antigenic determinants, as detected by immunofluorescence, but also because they have a similar geographical distribution, the same host range and often identical insect vectors. We show here that whereas mouse anti-T. rangeli sera have significant cross reactivity with T. cruzi by immunofluorescence, they are entirely specific when tested by ELISA, using apparently similar antigen preparations. Immunoprecipitation analysis detected relatively little cross-reactivity between heterologous antisera and parasite combinations. Intriguingly, immunization with T. rangeli epimastigotes was much more powerful than similar immunization with trypomastigotes, and the majority of the antibody was directed against a single polypeptide of apparent Mr 73kDa.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2868633

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  7 in total

1.  Variable sensitivity to complement-mediated lysis among Trypanosoma rangeli reference strains.

Authors:  Maria Auxiliadora de Sousa; Sheila Medeiros Dos Santos Pereira; Barbara Neves Dos Santos Faissal
Journal:  Parasitol Res       Date:  2011-07-12       Impact factor: 2.289

2.  Trypanosoma rangeli Tejera, 1920, in chronic Chagas' disease patients under ambulatory care at the Evandro Chagas Clinical Research Institute (IPEC-Fiocruz, Brazil).

Authors:  Maria Auxiliadora de Sousa; Tatiana da Silva Fonseca; Barbara Neves Dos Santos; Sheila Medeiros Dos Santos Pereira; Cristina Carvalhal; Alejandro Marcel Hasslocher Moreno
Journal:  Parasitol Res       Date:  2008-06-18       Impact factor: 2.289

3.  Species-specific markers for the differential diagnosis of Trypanosoma cruzi and Trypanosoma rangeli and polymorphisms detection in Trypanosoma rangeli.

Authors:  Keila Adriana Magalhães Ferreira; Emanuella Francisco Fajardo; Rodrigo P Baptista; Andrea Mara Macedo; Eliane Lages-Silva; Luis Eduardo Ramírez; André Luiz Pedrosa
Journal:  Parasitol Res       Date:  2014-04-12       Impact factor: 2.289

4.  Prevalence, Genetic Characterization, and 18S Small Subunit Ribosomal RNA Diversity of Trypanosoma rangeli in Triatomine and Mammal Hosts in Endemic Areas for Chagas Disease in Ecuador.

Authors:  Sofia Ocaña-Mayorga; Fernanda Aguirre-Villacis; C Miguel Pinto; Gustavo A Vallejo; Mario J Grijalva
Journal:  Vector Borne Zoonotic Dis       Date:  2015-12-08       Impact factor: 2.133

5.  Identification of strain-specific B-cell epitopes in Trypanosoma cruzi using genome-scale epitope prediction and high-throughput immunoscreening with peptide arrays.

Authors:  Tiago Antônio de Oliveira Mendes; João Luís Reis Cunha; Rodrigo de Almeida Lourdes; Gabriela Flávia Rodrigues Luiz; Lucas Dhom Lemos; Ana Rita Rocha dos Santos; Antônia Cláudia Jácome da Câmara; Lúcia Maria da Cunha Galvão; Caryn Bern; Robert H Gilman; Ricardo Toshio Fujiwara; Ricardo Tostes Gazzinelli; Daniella Castanheira Bartholomeu
Journal:  PLoS Negl Trop Dis       Date:  2013-10-31

6.  Different serological cross-reactivity of Trypanosoma rangeli forms in Trypanosoma cruzi-infected patients sera.

Authors:  Milene H de Moraes; Alessandra A Guarneri; Fabiana P Girardi; Juliana B Rodrigues; Iriane Eger; Kevin M Tyler; Mário Steindel; Edmundo C Grisard
Journal:  Parasit Vectors       Date:  2008-07-08       Impact factor: 3.876

7.  Remarkable genetic diversity of Trypanosoma cruzi and Trypanosoma rangeli in two localities of southern Ecuador identified via deep sequencing of mini-exon gene amplicons.

Authors:  Jalil Maiguashca Sánchez; Salem Oduro Beffi Sueto; Philipp Schwabl; Mario J Grijalva; Martin S Llewellyn; Jaime A Costales
Journal:  Parasit Vectors       Date:  2020-05-14       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.